Literature DB >> 2065043

Mechanisms of hypertriglyceridemia in the coconut oil/cholesterol-fed rabbit. Increased secretion and decreased catabolism of very low density lipoprotein.

M Van Heek1, D B Zilversmit.   

Abstract

Rabbits fed a 14% coconut oil/0.5% cholesterol (CNO/Chol) diet develop mild to severe hypertriglyceridemia compared with rabbits fed a 14% olive oil/0.5% cholesterol (OO/Chol) diet. Lipids and apolipoprotein (apo) B were significantly higher in the very low density lipoprotein (VLDL) and intermediate density lipoprotein fractions from CNO/Chol than from OO/Chol rabbits. Yet, the particle diameters of these lipoproteins were similar in both diet groups, indicating that CNO/Chol rabbits had a much larger number of VLDL and intermediate density lipoprotein particles in plasma. Although the composition of CNO/Chol VLDL differed from that of OO/Chol VLDL, the rates of triglyceride hydrolysis of CNO/Chol VLDL and OO/Chol VLDL by postheparin lipoprotein lipase in vitro were the same, suggesting that VLDLs from the two diet groups were equally good substrates for lipoprotein lipase. To determine the mechanisms of hypertriglyceridemia in the CNO/Chol rabbit, triglyceride and apo B of CNO/Chol VLDL and OO/Chol VLDL were labeled with tritium-containing triolein and iodine-131 and injected intravenously into CNO/Chol and OO/Chol rabbits. The fractional clearance rate for triglyceride in OO/Chol rabbits was twice that of CNO/Chol rabbits, which parallels the previously observed differences in postheparin lipoprotein lipase activity. Although the average fractional removal of apo B did not differ between diet groups, there was a significant inverse relation between plasma cholesterol and apo B fractional clearance rate. We conclude that the hypertriglyceridemia and the enhanced hypercholesterolemia in the CNO/Chol rabbit results primarily from increased hepatic secretion of VLDL and a modest decrease in VLDL triglyceride clearance capacity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065043     DOI: 10.1161/01.atv.11.4.918

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  7 in total

1.  Different effect of simvastatin and atorvastatin on key enzymes involved in VLDL synthesis and catabolism in high fat/cholesterol fed rabbits.

Authors:  J C Verd; C Peris; M Alegret; C Díaz; G Hernández; M Vázquez; T Adzet; J C Laguna; R M Sánchez
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Mechanisms mediating lipoprotein responses to diets with medium-chain triglyceride and lauric acid.

Authors:  Y H Tsai; S Park; J Kovacic; J T Snook
Journal:  Lipids       Date:  1999-09       Impact factor: 1.880

3.  Soluble fiber and soybean protein reduce atherosclerotic lesions in guinea pigs. Sex and hormonal status determine lesion extension.

Authors:  E Cos; T Ramjiganesh; S Roy; S Yoganathan; R J Nicolosi; M L Fernandez
Journal:  Lipids       Date:  2001-11       Impact factor: 1.880

4.  In Silico and Wet Lab Studies Reveal the Cholesterol Lowering Efficacy of Lauric Acid, a Medium Chain Fat of Coconut Oil.

Authors:  Devi Lekshmi Sheela; Puthiyaveetil Abdulla Nazeem; Arunaksharan Narayanankutty; Jeksy Jos Manalil; Achuthan C Raghavamenon
Journal:  Plant Foods Hum Nutr       Date:  2016-12       Impact factor: 3.921

5.  The mechanism of dietary cholesterol effects on lipids metabolism in rats.

Authors:  Yu-Ming Wang; Bei Zhang; Yong Xue; Zhao-Jie Li; Jing-Feng Wang; Chang-Hu Xue; Teruyoshi Yanagita
Journal:  Lipids Health Dis       Date:  2010-01-14       Impact factor: 3.876

6.  Carbohydrate type and amount alter intravascular processing and catabolism of plasma lipoproteins in guinea pigs.

Authors:  M L Fernandez; A K Conde; L R Ruiz; C Montano; J Ebner; D J McNamara
Journal:  Lipids       Date:  1995-07       Impact factor: 1.880

7.  JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs.

Authors:  Dimple Aggarwal; Kristy L West; Tosca L Zern; Sudeep Shrestha; Marcela Vergara-Jimenez; Maria Luz Fernandez
Journal:  BMC Cardiovasc Disord       Date:  2005-09-27       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.